Van Leuven F, Thiry E, Stas L, Nelissen B
Center for Human Genetics, Flemish Institute for Biotechnology, K. U. Leuven, Campus Gasthuisberg, Leuven, B-3000, Belgium.
Genomics. 1998 Sep 1;52(2):145-51. doi: 10.1006/geno.1998.5413.
The lipoprotein receptor-associated protein (RAP) is considered a chaperone protein for the lipoprotein receptor-related protein (LRP) and for the other members of the LDL receptor family. Genetic analysis is anticipated to help in delineating groups or individuals with potential defects or problems in this regard. A combined amplification/sequencing strategy was developed to analyze the human LRPAP1 gene for polymorphisms and mutations. The LRPAP1 gene was amplified from genomic DNA in four long-range PCR amplicons, 2.4 to 7.6 kb in size. Three amplicons were finally used as templates with 14 sequencing primers to obtain the sequence of the eight exons and large portions of adjacent introns from individual DNA. This strategy, applied to sequence the LRPAP1 gene of 14 unrelated, normal individuals revealed, in total, 23 distinct mutations and polymorphisms, mostly intronic substitutions and deletions. In this small group 1 expressed mutation was encountered on one allele in 2 unrelated individuals: a G to A transition results in the replacement of valine by methionine in exon 7 at position 311 of the human RAP precursor protein.
脂蛋白受体相关蛋白(RAP)被认为是脂蛋白受体相关蛋白(LRP)以及低密度脂蛋白受体家族其他成员的分子伴侣蛋白。预计基因分析将有助于识别在这方面存在潜在缺陷或问题的人群或个体。我们开发了一种联合扩增/测序策略来分析人类LRPAP1基因的多态性和突变。从基因组DNA中扩增出4个长距离PCR扩增子中的LRPAP1基因,大小为2.4至7.6 kb。最后将3个扩增子用作模板,使用14条测序引物从个体DNA中获得8个外显子以及相邻内含子大部分区域的序列。将该策略应用于对14名不相关的正常个体的LRPAP1基因进行测序,总共发现了23种不同的突变和多态性,大多为内含子替换和缺失。在这个小群体中,在2名不相关个体的一个等位基因上遇到了1个表达突变:一个G到A的转换导致人类RAP前体蛋白第311位外显子7中的缬氨酸被甲硫氨酸取代。